PatientFi® announced it has expanded its co-marketing agreement with Allergan Aesthetics to provide financing options for patients interested in treatments such as BOTOX® Cosmetic (onabotulinumtoxinA), JUVÉDERM® Collection of Fillers, Natrelle® breast implants for breast augmentation, CoolSculpting® and DiamondGlow®. PatientFi strives to remove cost barriers and replace them with a friendly financing solution, helping patients afford the treatments they desire, and in turn, helps practices empower more people to reach their aesthetic goals. In February 2021, PatientFi and Allergan Aesthetics began the initial phase of their marketing partnership.

The companies achieved breakout success by providing customized financing options for patients interested in breast augmentation with the Allergan Aesthetics Natrelle® line of breast implants. The strategic partnership contributed to a 56% increase in sales of Natrelle® breast implants to participating practices. PatientFi and Allergan Aesthetics saw a 2X increase in sales in participating practices in comparison to sales within practices that did not offer PatientFi.

Building off this success, the expanded partnership will now allow qualifying patients to pay for treatments and procedures using eligible Allergan Aesthetics products through PatientFi's friendly monthly payment plans and promotional financing options.